Filing Details

Accession Number:
0001209191-21-045827
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-07 16:47:51
Reporting Period:
2021-07-02
Accepted Time:
2021-07-07 16:47:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235912 Cvrx Inc. CVRX Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236049 P L 10 Partners Nea 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1237289 D Scott Sandell 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-02 58,175 $0.00 58,175 No 4 C Indirect See Note 2
Common Stock Acquisiton 2021-07-02 57,241 $0.00 115,416 No 4 C Indirect See Note 2
Common Stock Acquisiton 2021-07-02 71,077 $0.00 186,493 No 4 C Indirect See Note 2
Common Stock Acquisiton 2021-07-02 80,178 $0.00 266,671 No 4 C Indirect See Note 2
Common Stock Acquisiton 2021-07-02 83,396 $0.00 350,067 No 4 C Indirect See Note 2
Common Stock Acquisiton 2021-07-02 253,605 $0.00 603,672 No 4 C Indirect See Note 2
Common Stock Acquisiton 2021-07-02 1,196,911 $0.00 1,800,583 No 4 C Indirect See Note 2
Common Stock Acquisiton 2021-07-02 225,500 $18.00 2,026,083 No 4 P Indirect See Note 2
Common Stock Acquisiton 2021-07-02 14,933 $0.00 16,317 No 4 C Indirect See Note 4
Common Stock Acquisiton 2021-07-02 9,333 $0.00 25,650 No 4 C Indirect See Note 4
Common Stock Acquisiton 2021-07-02 10,371 $0.00 36,021 No 4 C Indirect See Note 4
Common Stock Acquisiton 2021-07-02 19,666 $0.00 55,687 No 4 C Indirect See Note 4
Common Stock Acquisiton 2021-07-02 92,951 $0.00 148,638 No 4 C Indirect See Note 4
Common Stock Acquisiton 2021-07-02 24,750 $18.00 173,388 No 4 P Indirect See Note 4
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Note 2
No 4 C Indirect See Note 2
No 4 C Indirect See Note 2
No 4 C Indirect See Note 2
No 4 C Indirect See Note 2
No 4 C Indirect See Note 2
No 4 C Indirect See Note 2
No 4 P Indirect See Note 2
No 4 C Indirect See Note 4
No 4 C Indirect See Note 4
No 4 C Indirect See Note 4
No 4 C Indirect See Note 4
No 4 C Indirect See Note 4
No 4 P Indirect See Note 4
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-2 Preferred Stock Disposition 2021-07-02 2,300,708 $0.00 58,175 $0.00
Common Stock Series B-2 Preferred Stock Disposition 2021-07-02 2,263,778 $0.00 57,241 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2021-07-02 2,810,950 $0.00 71,077 $0.00
Common Stock Series D-2 Preferred Stock Disposition 2021-07-02 3,170,896 $0.00 80,178 $0.00
Common Stock Series E-2 Preferred Stock Disposition 2021-07-02 3,298,154 $0.00 83,396 $0.00
Common Stock Series F-2 Preferred Stock Disposition 2021-07-02 10,029,566 $0.00 253,605 $0.00
Common Stock Series G Preferred Stock Disposition 2021-07-02 18,934,168 $0.00 1,196,911 $0.00
Common Stock Series B-2 Preferred Stock Disposition 2021-07-02 590,551 $0.00 14,933 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2021-07-02 369,115 $0.00 9,333 $0.00
Common Stock Series D-2 Preferred Stock Disposition 2021-07-02 410,162 $0.00 10,371 $0.00
Common Stock Series F-2 Preferred Stock Disposition 2021-07-02 777,752 $0.00 19,666 $0.00
Common Stock Series G Preferred Stock Disposition 2021-07-02 1,470,416 $0.00 92,951 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Upon the closing of the Issuer's initial public offering, each share of Series A-2 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock, Series D-2 Convertible Preferred Stock, Series E-2 Convertible Preferred Stock and Series F-2 Convertible Preferred Stock automatically converted into shares of common stock at a rate of 1-for-0.025857287.
  2. The securities are directly held by New Enterprise Associates 10, Limited Partnership ("NEA 10") and indirectly held by NEA Partners 10, the sole general partner of NEA 10, and Scott D. Sandell, the individual general partner of NEA Partners 10 (NEA Partners 10 and Mr. Sandell, together, the "NEA 10 Indirect Reporting Persons"). The NEA 10 Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 10 in which the NEA 10 Indirect Reporting Persons have no pecuniary interest.
  3. Upon the closing of the Issuer's initial public offering, each share of Series G Convertible Preferred Stock automatically converted into shares of common stock at a rate of 1-for-0.0632143218.
  4. The securities are directly held by New Enterprise Associates 8A, Limited Partnership ("NEA 8A") and are indirectly held by NEA Partners 10, Limited Partnership ("NEA Partners 10"), the sole general partner of NEA 8A, and Scott D. Sandell, the individual general partner of NEA Partners 10 (NEA Partners 10 and Mr. Sandell, together, the "NEA 8A Indirect Reporting Persons"). The NEA 8A Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 8A in which the NEA 8A Indirect Reporting Persons have no pecuniary interest.
  5. Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of common stock at the then-appliable conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the common stock.